(Q73670346)

English

Effect of adjuvant chemotherapy on outcome in patients with metastatic breast carcinoma treated with first-line doxorubicin-containing chemotherapy

scientific article published on 01 March 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267952%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Effect of adjuvant chemotherapy on outcome in patients with metastatic breast carcinoma treated with first-line doxorubicin-containing chemotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267952%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

based on heuristic

inferred from title

breast carcinoma

1 reference

based on heuristic

inferred from title

Matthieu Carton

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267952%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

J Y Pierga

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267952%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

B Asselain

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267952%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M Jouve

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267952%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

V Diéras

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267952%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

V Laurence

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267952%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

V Girre

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267952%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

P Beuzeboc

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267952%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

T Palangié

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267952%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

T Dorval

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267952%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

P Pouillart

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267952%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

0 references

publication date

1 March 2001

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267952%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267952%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

91

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267952%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267952%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1079-1089

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267952%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010315%2991%3A6%3C1079%3A%3AAID-CNCR1103%3E3.0.CO%3B2-S

21 January 2018

Results and long term follow-up for 1581 patients with metastatic breast carcinoma treated with standard dose doxorubicin-containing chemotherapy: a reference

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010315%2991%3A6%3C1079%3A%3AAID-CNCR1103%3E3.0.CO%3B2-S

21 January 2018

Classification of patients with disseminated cancer of the breast

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010315%2991%3A6%3C1079%3A%3AAID-CNCR1103%3E3.0.CO%3B2-S

21 January 2018

Multivariate analysis of prognostic factors in metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010315%2991%3A6%3C1079%3A%3AAID-CNCR1103%3E3.0.CO%3B2-S

21 January 2018

Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010315%2991%3A6%3C1079%3A%3AAID-CNCR1103%3E3.0.CO%3B2-S

21 January 2018

Prognostic factors in recurrent breast cancer: relationships to site of recurrence, disease-free interval, female sex steroid receptors, ploidy and histological malignancy grading

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010315%2991%3A6%3C1079%3A%3AAID-CNCR1103%3E3.0.CO%3B2-S

21 January 2018

Factors predicting for response, time to treatment failure, and survival in women with metastatic breast cancer treated with DAVTH: a prospective Eastern Cooperative Oncology Group study.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010315%2991%3A6%3C1079%3A%3AAID-CNCR1103%3E3.0.CO%3B2-S

21 January 2018

Effects of adjuvant chemotherapy on the natural history and likelihood of therapeutic efficacy in advanced breast cancer patients: a critical literature review

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010315%2991%3A6%3C1079%3A%3AAID-CNCR1103%3E3.0.CO%3B2-S

21 January 2018

Response to chemotherapy after relapse in patients with or without previous adjuvant chemotherapy for breast cancer. The French Epirubicin Study Group

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010315%2991%3A6%3C1079%3A%3AAID-CNCR1103%3E3.0.CO%3B2-S

21 January 2018

The influence of adjuvant chemotherapy on outcome after relapse for patients with breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010315%2991%3A6%3C1079%3A%3AAID-CNCR1103%3E3.0.CO%3B2-S

21 January 2018

Factors predicting long-term survival for metastatic breast cancer patients treated with high-dose chemotherapy and bone marrow support

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010315%2991%3A6%3C1079%3A%3AAID-CNCR1103%3E3.0.CO%3B2-S

21 January 2018

Effect of adjuvant chemotherapy with or without anthracyclines on the activity and efficacy of first-line cyclophosphamide, epidoxorubicin, and fluorouracil in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010315%2991%3A6%3C1079%3A%3AAID-CNCR1103%3E3.0.CO%3B2-S

21 January 2018

Randomized trial comparing protracted infusion of 5-fluorouracil with weekly doxorubicin and cyclophosphamide with a monthly bolus FAC regimen in metastatic breast carcinoma (SPM90)

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010315%2991%3A6%3C1079%3A%3AAID-CNCR1103%3E3.0.CO%3B2-S

21 January 2018

Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010315%2991%3A6%3C1079%3A%3AAID-CNCR1103%3E3.0.CO%3B2-S

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010315%2991%3A6%3C1079%3A%3AAID-CNCR1103%3E3.0.CO%3B2-S

21 January 2018

Effect of systemic adjuvant treatment on first sites of breast cancer relapse.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010315%2991%3A6%3C1079%3A%3AAID-CNCR1103%3E3.0.CO%3B2-S

21 January 2018

Significance of axillary lymph node metastasis in primary breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010315%2991%3A6%3C1079%3A%3AAID-CNCR1103%3E3.0.CO%3B2-S

21 January 2018

Sequential assessment of multidrug resistance phenotype and measurement of S-phase fraction as predictive markers of breast cancer response to neoadjuvant chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010315%2991%3A6%3C1079%3A%3AAID-CNCR1103%3E3.0.CO%3B2-S

21 January 2018

Detection and clinical importance of micrometastatic disease

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010315%2991%3A6%3C1079%3A%3AAID-CNCR1103%3E3.0.CO%3B2-S

21 January 2018

Effect of a National Cancer Institute Clinical Alert on breast cancer practice patterns

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010315%2991%3A6%3C1079%3A%3AAID-CNCR1103%3E3.0.CO%3B2-S

21 January 2018

Confirmation of a prognostic index for patients with metastatic breast cancer treated by endocrine therapy

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010315%2991%3A6%3C1079%3A%3AAID-CNCR1103%3E3.0.CO%3B2-S

21 January 2018

Oestrogen receptors, sites of metastatic disease and survival in recurrent breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010315%2991%3A6%3C1079%3A%3AAID-CNCR1103%3E3.0.CO%3B2-S

21 January 2018

Steroid-hormone receptors and survival after first relapse in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010315%2991%3A6%3C1079%3A%3AAID-CNCR1103%3E3.0.CO%3B2-S

21 January 2018

The effect of oestrogen and progesterone receptors on recurrence and survival in patients with carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010315%2991%3A6%3C1079%3A%3AAID-CNCR1103%3E3.0.CO%3B2-S

21 January 2018

Oestrogen receptors in primary and advanced breast cancer: an eight year review of 704 cases

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010315%2991%3A6%3C1079%3A%3AAID-CNCR1103%3E3.0.CO%3B2-S

21 January 2018

Oestrogen-receptor status and sites of metastasis in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010315%2991%3A6%3C1079%3A%3AAID-CNCR1103%3E3.0.CO%3B2-S

21 January 2018

Construction and validation of a practical prognostic index for patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010315%2991%3A6%3C1079%3A%3AAID-CNCR1103%3E3.0.CO%3B2-S

21 January 2018

Pattern of dissemination and survival following isolated locoregional recurrence of breast cancer. A prospective study with more than 10 years of follow up

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010315%2991%3A6%3C1079%3A%3AAID-CNCR1103%3E3.0.CO%3B2-S

21 January 2018

Clinical course of breast cancer patients with liver metastases

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010315%2991%3A6%3C1079%3A%3AAID-CNCR1103%3E3.0.CO%3B2-S

21 January 2018

Identifiers

10.1002/1097-0142(20010315)91:6<1079::AID-CNCR1103>3.0.CO;2-S

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267952%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267952%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73670346&oldid=2101844405"